FLI1 and scleroderma: Thus, the adenosine A2A receptor-mediated loss of inhibition of dermal matrix protein synthesis through regulation of Fli1, and the resultant increase in the production of matrix and profibrogenic growth factors such as CTGF, is likely a contributor to the pathogenesis of skin thickening in scleroderma.